long-term animals. At 16 weeks posttransplant, animals that received cells transduced by the GATA-1 virus maintained a lower white blood cell (WBC) count and absolute neutrophil count (ANC) and a higher red blood cell (RBC) count than control animals that received cells transduced with a virus containing a neo' gene. Erythropoiesis was stimulated in GATA-1 and control animals by phlebotomy. GATA-l animals required more extensive phlebotomy t o reach a hematocrit less than 25 and their hematocrit returned t o normal levels sooner than control animals. The effect of twice-daily injections of 10 U recombinant erythropoietin (epo) was also examined. The hematocrit of GATA-1 animals showed a more rapid and elevated response t o epo than the hematocrit of control animals. These data suggest that dysregulated expression of GATA-1 in primitive hematopoietic cells enlarges the pool of epo-responsive erythroid progenitor cells. in the earliest definable sites of erythropoiesis in developing mousez6 and frogz7 embryos.
GATA-I and GATA-2 are both expressed at high levels in cell cultures enriched for erythroid precursor cells, but as the cells are induced to differentiate by treatment with epo, the GATA-2 level decreases while the GATA-1 gene continues to be expressed at high levels.** The observation that GATA-2 mRNA levels are significantly elevated in in vitro differentiated GATA-1 minus erythroid precursors suggests the involvement of GATA-I in the downregulation of GATA-2 during erythroid maturation." Additionally, enforced expression of a conditional GATA-2 gene, but not GATA-l or GATA-3, was sufficient to block erythroid differentiation." The expression data are consistent with a model in which GATA-I has a role in initiating erythroid development, possibly by induction of the epo receptor, and then GATA-l expression is increased through an autoregulatory mechanism further committing the cells to the erythroid lineage. '4 The GATA-I gene is located on the X chromosome in mice and human^.^ Targeted mutagenesis experiments in male embryonic stem (ES) cells have demonstrated that GATA-l is necessary for normal erythroid development, since mature red blood cells (RBCs) derived from the GATA-l minus ES cells are not detected in chimeric animals.'" The requirement for GATA-1 during erythropoiesis was confirmed in vitro by culture of the GATA-I minus ES cells in growth factor-supplemented methylcell~lose.~' Analysis of the in vitro differentiated GATA-1 minus ES cells showed a complete block in the formation of primitive erythroid precursors, but a normal number of definitive precursors that underwent developmental arrest and death at the proerythroblast stage. 2y We reasoned that uncontrolled expression of a GATA-l gene in the most primitive hematopoietic cells would alter hematopoiesis in the mouse in such a way as to identify the earliest progenitor cells that are affected by GATA-1. To test this, we generated a retroviral vector, PGK-GATA-1, containing a mouse GATA-1 gene linked to the constitutive promoter from the human phosphoglycerate kinase (PGK) 
MATERIALS AND METHODS
Plasmid construction. The murine GATA-1 cDNA2 in the vector pXM-GF-l was a gift from Dr Stuart Orkin. The GATA-l coding sequence was removed by NcoI-ScaI digestion and subcloned into the pG3NaP-globin vector (a derivative of pG3Na from Genetics Therapy, Inc, Gaithersburg, MD), which was first digested with BamHI, filled in, and then partially digested with NcoI to generate pG3-P-mGATA-I. The human PGK gene promote82 was digested with EcoRI and PvuII and substituted for the P-globin promoter to generate the PGK-GATA-1 vector (Fig 1) . The PGK-GATA-1 vector expresses the murine GATA-l gene under the control of the PGK promoter, and contains the 3' end of the @-globin gene including the second intervening sequence (IVS-2) and the polyadenylation site downstream of the GATA-1 coding sequence.
Cells. Unless otherwise noted, cell culture supplies were obtained from Life Technologies, Inc, Grand Island, NY. The GP + E-86 cell line34 and the producer cell lines derived from it, PGK-GATA-l no. 34 and PGK-GATA-l no. 18, were maintained in Q-2 medium: Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% newborn calf serum, 4 mmoVL glutamine, 50 U/ mL penicillin G, and 50 pg/mL streptomycin sulfate. PA317 cells35
were maintained in W10 medium: Improved Minimal Essential Medium with 10% fetal calf serum. The N2-536 cell line was used as a control for these experiments, and was maintained in Q-2 medium. The N2-5 cell line produces the N2 retrovirus, which contains the neo gene. The N2 vector is nearly identical to the pG3Na backbone used to generate PGK-GATA-1, except that pG3Na has a plylinker replacing envelope sequence adjacent to the 3'LTR. were maintained in W10 medium. Virus production. To generate the ecotropic producer cell lines, the PA317 amphotropic packaging cell line was transfected with 10 pg PGK-GATA-l plasmid DNA using a Cellphect Kit (Pharmacia, Piscataway, NJ). Two days posttransfection, the supernatant was collected and serial dilutions were used to infect GP + E-86 cells for 24 hours in the presence of 6 pg/mL Polybrene (Sigma, St Louis, MO). Following the infection period, GP + E-86 cells were passed at dilutions ranging from 1:lO to 1:160 into Q-2 medium. The cells were incubated for 24 hours before the medium was changed to Q-2 containing G418 (500 pg/mL active). After G418 selection, individual colonies were collected and examined for virus production by RNA slot-blot analysis" of the cellular supernatant. DNA from cell clones producing high viral titers was tested for proviral integrity by Southern blot analysis. The PGK-GATA-l no. 34 and PGK-GATA-1 no. 18 cell lines were used in the studies reported here.
Mice. All animals were purchased from Jackson Laboratory (Bar Harbor, ME). Female C57BW6J mice, which are homozygous for the "single" hemoglobin allele at the P-globin locus (Hbbs/Hbbs), were used as the donor animals. The recipients were histocompatable female WBB6FI-WN' mice (W/W')?* which are heterozygous at the P-globin locus (HbbS/Hbbd), giving a "single-diffuse'' hemoglobin pattern.
Bone marrow transduction and long-term reconstitution. Bone marrow transduction was performed largely as previously de~cribed.'~ Female C57BL/6J donor mice were treated with 5-flUOrOuracil (Fluka, Ronkonkoma, NY) 150 mgkg body weight 2 days before bone marrow harvest. Bone marrow cells were harvested from the hind limbs and prestimulated for 2 days by culture at 2 X lo5 cells/mL in infection medium: DMEM supplemented with 15% fetal calf serum (Hyclone, Logan, UT), 4 mmom glutamine, 50 U/ Methylcellulose colony assays. Bone marrow cells were harvested from female C57BL16J mice and transduced by supematant infection using filtered supernatant harvested from confluent plates of producer cells; 5 X IO6 bone marrow cells were incubated in I O mL fresh viral supernatant supplemented with Polybrene, IL-3, IL-6, and SCF as described above. The medium was changed twice, at 12 and 24 hours after plating, and the cells were collected and counted 36 hours after the initial transduction period was initiated. Mock transduced cells were cultured as above in infection medium supplemented with Polybrene and cytokines. The cells were resuspended at 5 X lo5 cells/mL in DMEM plus 2% fetal calf serum (Hyclone), and 0.3 mL of cells were added to tubes containing 3 mL of methylcellulose mix (Methocult M3430; Stemcell Technologies Inc, Vancouver, British Columbia, Canada) supplemented with 100 ng/mL m-SCF, 2.5 ng/mL rm-IL-3, and 50 ng/mL rh-IL-6. G418 was added to the methylcellulose mix to generate final concentrations of 1.0 or 1.25 mg/mL. Duplicate 35-mm plates containing 1 . l mL of the methylcellulose mix and 5 X IO4 cells were incubated at 37°C. Colony-forming unit-granulocyte/macrophage (Cm-GM) colonies were counted on day 7, and burst-forming unit-erythroid (BFU-E) colonies were counted on day 10
Hematology. Peripheral blood was collected into heparinized capillary tubes (Thomas Scientific, Swedesboro, NJ) from the retrooribital sinus of long-term reconstituted animals beginning 12 weeks posttransplant. Hemoglobin conversion from the recipient phenotype (single-diffuse) to the donor phenotype (single) was monitored by electrophoresis of blood samplesa on cellulose acetate gels (Helena Laboratories, Beaumont, TX). Hematocrits were determined after centrifugation of blood containing capillary tubes in an IEC (Needham, MA) microcapillary centrifuge. WBC and RBC counts were determined using a Coulter ZM counter (Coulter Electronics, Hialeah, FL). Mean corpuscular volume (MCV) was calculated by dividing the relative volume of packed RBCs (mL packed RBCs/1,000 mL blood) by the RBC count (RBC X 10y/mL). Differential cell counts (100 cells) were performed on Wright's-stained peripheral blood smears, and ANCs were calculated by multiplying the percent of granulocytes determined by differential counts by the WBC count.
For the epo response experiment. 10 U recombinant human epo ([rh-epo] Ortho, Raritan, NJ) in 0.1 mL PBS (Biofluids, Rockville, MD) was injected subcutaneously twice per day. Control animals received the same volume of PBS.
DNA analysis. Southern blots4' were performed using standard techniques and Hybond N+ paper (Amersham, Arlington Heights, IL). The probes were "P-labeled using a random primed Oligo Labeling kit (Pharmacia). The DNA probes ( Fig 1C) used were gelpurified restriction fragments generated as follows: neo probe, BglIINcol fragment from pSV2-neo (Clonetech, Palo Alto, CA); IVS-2 probe, BamHI-EcoRI containing the human &globin IVS2 sequence; and GATA-IAVS-2 probe, EcoRI fragment from PGK-GATA-1.
Genomic DNA was isolated from 200 pL peripheral blood and subjected to polymerase chain reaction (PCR) analysis using reagents and protocols supplied by the manufacturer (Perkin-Elmer, Norwall, CT). DNA was amplified for 25 cycles of 94°C X 1.5 minutes, 58°C X 1 minute. and 72°C X 1.5 minutes, followed by one cycle of 72°C X 7 minutes. Primer pairs specific for the neo gene (S'-TCCATC-ATGGCTGATGCAATGCGGC-3' and 5'-GATAGAAGGCGA-TGCGCTGCGAATCG-3') and the PGK-driven GATA-I gene (5'-ATTCTGCAAGCCTCCGGAGCGC-3' and 5'-CAGTTGAGG-CAGGGTAGAGTGC-3'). as well as the murine p-actin gene (5'-CATTGTGATGGACTCCGGAGACGG-3' and S'-CATCTC-CTGCTCGAAGTCTAGAGC-3'). were used.
mRNA unalysis. Total cellular RNA was isolated from spleen cells of long-term reconstituted animals using RNAzol B (Tel-Test Inc, Freindswood, TX). First-strand cDNA synthesis was achieved by incubating 1 pg RNA in a volume of 3 pL Diethyl pyrocarbonate (Fluka) treated water with 4 pL 20-mmoVL MgCI2, 2 pL lox PCR buffer 11, 2 pL of each deoxynucleoside triphosphate, I pL SOpmoVL random hexamers, 1 //L RNAse inhibitor, and I pL reverse transcriptase, according to the manufacturer's instructions (PerkinElmer-Cetus, Nonvalk, CT). The rubes were incubated at room temperature for 15 minutes, 42°C for 20 minutes, 98°C for 5 minutes, and 4°C for 5 minutes.
cDNA was amplified using 10 yL of the reaction mixture incubated with the murine p-actin and PGK-GATA-1 primers described earlier, along with 2 @L 20-mmoUL MgCI,, 4 pL I O X PCR buffer 11, 0.2 p L rr-32P-deoxycytidine triphosphate (Amersham), and 0.5 pL Ampli Taq DNA polymerase in a final volume of 50 pL. cDNA was amplified for 25 cycles of 94°C X 1.5 minutes, 58°C X 1 minute, and 72°C X 1.5 minutes, followed by one cycle of 72°C X 7 minutes.
Xuper-shijt analysis. Nuclear extracts of CTLL, CTLL-GATA-1, and MEL cells were prepared by the method of Dignam et al,4' aliquoted, and stored at -70°C. Protein concentrations were determined using a BioRad (Hercules, CA) DC protein assay. Gel shifts were performed as previously described.43 Ten micrograms of protein extract was incubated at 4°C for 20 minutes with 20,000 cpm radiolabeled oligonucleotide probe containing either a GATA-I (from the 195 to -165 region of the human y-globin gene promoter") or Sp-l (from the SV40 enhanceri6) binding site. To appropriate tubes, 100 ng monoclonal antibody directed against GATA-I or GATA-3 (Santa Cruz Biotechnology, Santa Cruz, CA) or nonspecific antibodies of the same or different isotypes were added and incubated overnight at 4°C. DNA-protein complexes were electrophoresed on 4% nondenaturing polyacrylamide gels in 0.25X Trisborate-EDTA buffer, dried, and autoradiographed.
RESULTS
PGK-GATA-1 vector produces authentic murine GATA-1. The retroviral vector, PGK-GATA-l (Fig IA) , has two promoters, the viral LTR promoter and the PGK promoter, which operate in opposite transcriptional orientations. The gene for neomycin resistance is expressed from the LTR promoter, and the PGK promoter drives expression of the murine GATA-I gene. Ecotropic retrovirus-producing cell clones were generated using the GP + E-8637 packaging cell line. Cell clones designated PGK-GATA-1 no. 34 and PGK-GATA-l no. 18 were isolated and shown to contain a single full-length copy of the provirus by Southern blot analysis (data not shown).
To confirm the expression of authentic GATA-l in transduced cells, supernatant from PGK-GATA-I no. 34 cells was used to transduce the GATA-1 -negative, IL-2-dependent murine CTLL (CTLL-2),33 and transduced cells were selected in G418 for 2 weeks (CTLL-GATA-1). To demonstrate expression of authentic exogenous GATA-l protein, super-shift analysis was performed on nuclear extracts of the parental CTLL-2 cell line, and CTLL cells transduced by the PGK-GATA-I vector (Fig 2) . Extracts from MEL cells, which express GATA-1 (lanes 1 to S), were used as controls for this experiment. The mobility of the GATA-I:DNA complex (lane 1) is shifted by incubation with a monoclonal antibody specific for GATA-1 (lane 4), but is unaffected by incubation with nonspecific antibodies of the same isotype (lane 2). a different isotype (lane 3), or a monoclonal antibody against GATA-3 (lane 5). Little GATA-I is seen in the parent CTLL-2 cells (lanes 6 to 9). even though equal amounts of extract were used as demonstrated by incubation of the extracts with an oligonucleotide containing an SP-I protein binding site (data not shown). With extracts from CTLL-GATA-I cells (lanes I O to 13), a super shift was observed only when the GATA-I -specific antibody was incubated with the extract (lane 12), not when antibody against GATA-3 (lane 13) or nonspecific antibodies (lanes 10 and 11) were used. These results confirm the production of authentic murine GATA-I derived from the PGK-GATA-I vector.
Long-term gene transfer. To study the effects of dysregulated GATA-l gene expression, bone marrow cells from C57BL/6J animals were transduced in vitro by co-culture with the PGK-GATA-I virus producer cell line or the N2 virus producer cell line, collected, and injected into the tail vein of W/W" recipient animals. Beginning 12 weeks posttransplant, reconstitution with donor marrow was monitored by hemoglobin electrophoresis. All animals used in these experiments had the single hemoglobin phenotype of the donor animals, as opposed to the single-diffuse hemoglobin phenotype of the recipients (data not shown). Efficient transduction of the donor marrow was demonstrated by PCR analysis of DNA isolated from peripheral blood cells (Fig   3) . Primer pairs (Fig 1B) that amplify a 41 l-bp fragment from the PGK-GATA-I gene (Fig 3A) or a 433-bp segment of the neo gene ( Fig 3B) were used to identify the provirus, while primers that amplify a 232-bp product of the endogenous mouse @-actin gene ( Fig 3B) were used as an internal control for the DNA content of the samples. Bands of the appropriate size for &actin, neo, and PGK-GATA-I were amplified from DNA extracted from the PGK-GATA-I no. 18 producer cell line (Fig 3A and B, lane 3) , and only the &actin band was amplified from DNA extracted from the parental GP + E-86 cell line (Fig 3A and B, lane 2) . Bands of the appropriate size were observed when PGK-GATA-I primers or neo primers were used to amplify DNA extracted from the peripheral blood of long-term animals reconstituted with cells transduced by the PGK-GATA-I virus (Fig 3A  and B, lanes 6 to 9) . DNA from animals reconstituted with cells transduced by the N2 producer cell line amplified with the neo primers (Fig 3B, lanes 4 and S) , but not with the PGK-GATA-I primers (Fig 3A, lanes 4 and S) . At 16 weeks posttransplant, 33 of 38 animals (87%) receiving cells transduced by the PGK-GATA-I no. 34 cell line had detectable viral sequences. Animals that were negative for the viral genes in the PCR assay were excluded from the study.
Southern blot analysis of DNA from bone marrow, spleen, and thymus tissues of long-term animals was performed 6 to IO months posttransplant to demonstrate viral integration, proviral integrity, and copy number. Using a .probe to the neo sequences (Fig IC) , a 3.3-kb band is seen in KpnIdigested DNA from the N2-S producer cell line (Fig 4A,  lane 2 ) and the bone marrow of an N2 animal (Fig 4A, lane  4) . The same probe hybridizes to a 5.2-kb band from KpnIdigested PGK-GATA-I no. 34 DNA (Fig 4A, lane 3) and DNA from bone marrow cells of GATA-I animals (Fig 4A,   For lanes 6 to 8 and IO to 12). These are the predicted sizes of Kpnl digests of the full-length N2 and PGK-GATA-1 proviral constructs. A 4.0-kb band is also observed in DNA from the PGK-GATA-I no. 34 producer cell line (lane 3) and several long-term animals (lanes 7 to 12). When the same DNA digests were hybridized to a probe containing the human &globin IVS-2 sequences (Fig IC) , the 4.0-kb band is not seen but the full-length 5.2-kb band is still visible (Fig   4B) , indicating When the IVS-2-GATA-I probe (Fig IC) was used, both the 5.2-and 4.0-kb bands were visible, as well as a highermolecular-weight band representing the endogenous GATA-1 band (data not shown). By comparing intensity of the endogenous GATA-I band with that of the full-length viral band using a phosphorimager (Molecular Dynamics, Sunnyvale, CA), an estimate of exogenous GATA-I gene copy number was determined. The mice studied had an average 1 to 4) and PGK-GATA-1 (lanes  6 to 14) animals was analyzed. The position of bands representing p-actin and proviral GATA-1 rnRNAs is indicated. Neither signal was detected in the sample in lanes 5 and 7.
copy number of approximately 0.5 exogenous GATA-I genes per cell (data not shown).
E.rpression of viral RNA in long-term reconstituted animals. To demonstrate expression of the viral sequences, cellular RNA from spleen cells of long-term animals was isolated and analyzed by reverse transcriptase-PCR. The murine &actin-and PGK-GATA-1 -specific primer pairs ( Fig IB) were used to amplify cDNA generated from 1 pg RNA isolated from spleen cells 10 months after bone marrow transplant (Fig 5) . Bands representing only the &actin message are seen in samples from N2 animals (lanes 1 to 4), whereas both p-actin-and PGK-GATA-I -specific bands are seen in samples from eight of nine GATA-I animals (lanes 6 to 14) . No signal was observed in duplicate samples incubated initially without reverse transcriptase (data not shown), demonstrating the absence of DNA in the RNA samples.
Effect of dysregulated GATA-I expression on the hematolo g~ of long-term animals. The hematocrit, RBC count, and WBC count of recipient animals were examined beginning 12 weeks posttransplant. Data from animals examined 16 weeks posttransplant in three separate experiments are presented in Table 1 . PGK-GATA-1 animals consistently had higher RBC counts ( P = .005) and lower WBC counts ( P = .05) than N2 control animals. Even though there is a significant increase in the RBC value for GATA-I animals as compared with control animals, the hematocrits are similar. We calculated the MCV for the animals, and observed a significant decrease in the size of RBCs in GATA-I animals as compared with controls. The trends persisted for 6 months posttransplant or longer, but the data at each time point were not uniformly statistically significant. Examination of blood smears of animals from two separate experiments showed that GATA-I animals have a 55% lower ANC 4129 PGK-GATA-1 -0-Actin ( P = .038) than control animals ( Table l ) . Marrow and spleen cellularity did not appear to differ between controls and GATA-I animals.
Response to nnemin induced b.v phlebotomy. Erythroid precursor cells respond to epo by completing the maturation process''; however, at the low epo levels present in hematologically normal mice, only a fraction of the precursors become circulating erythrocytes and the remainder undergo apoptosis.?h-JX Production of epo by the kidney" can be induced by anemia, hypoxia, or heavy metals, with a resulting increase in erythropoiesis.5"To test the effect of dysregulated GATA-I expression on the response to anemia, 0.2 mL blood was collected from each mouse every day until an average hematocrit of less than 25 was reached for both N2 and GATA-I animals. Results from one of two similar experiments are shown in Fig 6. Hematocrits of GATA-I animals decreased at a slower rate than those of control animals (Fig  6) , and required a second phlebotomy on day -I to reach the desired hematocrit on day 0. Beginning on day 0, 50 pL of blood was removed each day so that hematocrits could be monitored while the animals recovered. Hematocrits of GATA-I animals increased rapidly; a 54% ( t 18.9%) increase was observed on day 1, as compared with a 19% ( t 1 1 . l %) increase for control animals (n = 3 for both groups, P = .049). GATA-I animals also returned to normal hematocrit levels sooner than control animals.
Response to epo injection. To examine further the effect of the exogenous GATA-I protein on erythropoiesis, GATA-1 and N2 animals were injected subcutaneously twice per day with I O U rh-epo in 0.1 mL PBS. Control groups received the same volume of saline twice per day. There was no significant difference between any groups after 3 days of treatment, and hematocrits of GATA-I and N2 animals receiving saline did not change throughout the experiment (Fig 7 and Table 2 ). Beginning on day 5, both GATA-1 and N2 animals began to respond to exogenous rh-epo, with GATA-1 animals consistently maintaining higher hematocrits. The differences were statistically significantly ( P < .05) on days 5,9, and 16 (Table 2) , and the mean hematocrits of GATA-1 animals peaked at 71 2 2.5 (day 16), versus 65.5 +-3.5 (day 16) for control animals (P = ,019).
Growth of hematopoietic progenitors in methylcellulose.
The dysregulated expression of GATA-1 in long-term reconstituted animals may influence the relative number of erythroid and myeloid progenitor cells. To examine the effect of GATA-1 expression in vitro, bone marrow cells were transduced by incubation with supernatant from retroviral producer cells and plated in methylcellulose. Between 12% and 64% of the colonies were G418-resistant depending on the cell line used for transductions. The number of BFU-E divided by the number of CFU-GM was twofold to fourfold higher among G41 8-resistant cells transduced with supernatant from PGK-GATA-l no. 18 and PGK-GATA-l no. 34 producer cell lines as compared with cells transduced with supernatant from the control N2-5 producer cell line ( P < .05; Table 3 ). All plates grown in the absence of G418 had similar numbers of total colonies, indicating that equivalent numbers of cells were added to each plate and that none of the viruses were toxic to the progenitors. PCR analysis of 26 randomly selected G418-resistant colonies showed that the PGK-GATA-1 or N2 provirus was present in each colony.
DISCUSSION
The exact role of GATA-1 during erythropoiesis is still unclear, even though much is known about the expression pattern of the GATA-1 gene and the genes it regulates. The requirement for functional GATA-1 during primitive and definitive erythropoiesis has been demonstrated by targeted mutagenesis in ES ~ells,3~~" with in vitro differentiation studies demonstrating that the definitive erythroid precursors die at the proerythroblast stage.29 Still, it is not clear which progenitor cell types are affected by GATA-1 expression, since the mRNA can be detected in the most primitive hematopoietic Ectopic expression of genes in transgenic mice has been used to identify the cell types affected by dysregulated expression of a variety of proteins. Retrovirus-mediated gene transfer into murine hematopoietic stem cells of the L 3 gene resulted in a myeloproliferative disorder caused by the expansion of myeloid progenitor cells." The phenotype of these animals was similar to that of animals repopulated with cells transduced with a retrovirus containing the bcr-abl gene associated with human chronic myelogenous le~kemia.~' Dysregulated E -6 expression resulted in proliferation of For personal use only. on November 11, 2017. by guest www.bloodjournal.org From Peripheral blood was collected from the number of mice in parentheses. Saline animals received twice-daily injections of 0.1 mL PBS, and epo animals received twice-daily injections of 10 U rh-epo in 0.1 mL PBS. Statistically significant ( P < ,051 differences.
early B cells and produced a syndrome with many similarities to Castleman's disease in h~mans.5~ Recently, we used retrovirus-mediated gene transfer to demonstrate that a mutation in the p45 NF-E2 geneM was not responsible for the defect in mWmk mice and that dysregulated p45 NF-E2 expression did not affect the RBC or WBC count in recipient animals. 55 The data presented in this report are consistent with a model in which dysregulated GATA-1 gene expression results in an expansion of the pool of epo-responsive erythroid progenitors. Our results are compatible with the model for epo's effect on erythroid precursors proposed by Koury et al?7,s6-58 in which a small percentage of CFU-E respond to the endogenous level of epo and complete their developmental program while the remainder undergo apoptosis. Increases in epo level by a variety of mechanisms result in an increased survival rate for erythroid precursors, and variation of the epo-sensitivity of individual precursors regulates the maturation process and may provide a sensitive switch for rapid increases in the rate of erythrocyte prod~ction?~ We propose that dysregulated expression of the GATA-1 gene causes multipotent myeloid progenitor cells similar to Cm-GM to become committed to an erythroid differentiation program. This results in an enlarged pool of epo-responsive progenitor cells, at the expense of the granulocyte-macrophage differentiation program. This would account for the higher RBC count and decreased WBC count and ANC in our GATA-1 -expressing animals. The decreased MCV observed in GATA-1 animals is consistent with accelerated erythropoiesis.
The magnitude of the response to dysregulated GATA-1 expression is almost certainly dampened by the fact that no more than 50% of the precursors have been transduced by the GATA-1 retrovirus. When epo levels are increased, either in response to phlebotomym or by injection of exogenous epo,6' our model predicts that more erythroid precursors are able to complete the erythroid maturation program. This would lead to a greater and more rapid response to epo in GATAl-expressing animals than in control animals. Our data on the in vitro effect of dysregulated GATA-1 expression on the growth of hematopoietic progenitor cells in methylcellulose are consistent with our in vivo data. The increased proportion of erythroid progenitor colonies relative to myeloid colonies suggests that multipotent progenitors can be recruited to erythroid commitment by increased levels of The ability to selectively initiate dysregulated GATA-1 expression would facilitate the testing of this model. Recently, a system in which promoter activity can be controlled by treatment with tetracycline has been described.62 Transcription factor genes under the control of such promoters in transgenic animals would permit the effects of dysregulated expression to be measured with greater accuracy.
GATA-1.
